162 related articles for article (PubMed ID: 31731402)
21. Inhibition of Opisthorchis felineus glutathione-dependent prostaglandin synthase by resveratrol correlates with attenuation of cholangiocyte neoplasia in a hamster model of opisthorchiasis.
Pakharukova MY; Zaparina OG; Kovner AV; Mordvinov VA
Int J Parasitol; 2019 Nov; 49(12):963-973. PubMed ID: 31628937
[TBL] [Abstract][Full Text] [Related]
22. A study of tribendimidine effects in vitro and in vivo on the liver fluke Opisthorchis felineus.
Pakharukova MY; Samsonov VA; Serbina EA; Mordvinov VA
Parasit Vectors; 2019 Jan; 12(1):23. PubMed ID: 30635027
[TBL] [Abstract][Full Text] [Related]
23. Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis: A systematic review.
Machicado C; Marcos LA
Int J Cancer; 2016 Jun; 138(12):2915-21. PubMed ID: 26840624
[TBL] [Abstract][Full Text] [Related]
24. Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer.
Gouveia MJ; Santos J; Brindley PJ; Rinaldi G; Lopes C; Santos LL; da Costa JM; Vale N
Cancer Lett; 2015 Apr; 359(2):226-32. PubMed ID: 25615421
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial.
Soukhathammavong P; Odermatt P; Sayasone S; Vonghachack Y; Vounatsou P; Hatz C; Akkhavong K; Keiser J
Lancet Infect Dis; 2011 Feb; 11(2):110-8. PubMed ID: 21111681
[TBL] [Abstract][Full Text] [Related]
26. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel.
Dechakhamphu S; Pinlaor S; Sitthithaworn P; Nair J; Bartsch H; Yongvanit P
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):310-8. PubMed ID: 20056652
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia.
Mekonnen A; Legesse M; Belay M; Tadesse K; Torben W; Teklemariam Z; Erko B
BMC Res Notes; 2013 Sep; 6():392. PubMed ID: 24073761
[TBL] [Abstract][Full Text] [Related]
28. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
Coles GC; Liang YS; Doenhoff MJ
Emerg Infect Dis; 2001; 7(6):1069-70. PubMed ID: 11747748
[No Abstract] [Full Text] [Related]
29. Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.
Thinkhamrop K; Khuntikeo N; Sithithaworn P; Thinkhamrop W; Wangdi K; Kelly MJ; Suwannatrai AT; Gray DJ
Infect Dis Poverty; 2019 Mar; 8(1):18. PubMed ID: 30890188
[TBL] [Abstract][Full Text] [Related]
30. Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis.
Sereerak P; Upontain S; Tangkawattana P; Mallory FF; Sripa B; Tangkawattana S
Parasitol Int; 2017 Aug; 66(4):448-452. PubMed ID: 27576001
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial.
Coulibaly JT; Panic G; Yapi RB; Kovač J; Barda B; N'Gbesso YK; Hattendorf J; Keiser J
BMC Med; 2018 Jun; 16(1):81. PubMed ID: 29855373
[TBL] [Abstract][Full Text] [Related]
32. Parasite-Associated Cancers (Blood Flukes/Liver Flukes).
Feng M; Cheng X
Adv Exp Med Biol; 2017; 1018():193-205. PubMed ID: 29052139
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
34. Granulin Expression in Hamsters during Opisthorchis viverrini Infection-Induced Cholangiocarcinogenesis.
Upontain S; Sereerak P; Laha T; Sripa B; Tangkawatana P; Brindley PJ; Tangkawatana S
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2437-2445. PubMed ID: 30255697
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
37. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
Buisson Y
Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
[TBL] [Abstract][Full Text] [Related]
38. Case Report: Hemianopia: From Suspected Glioblastoma to the Diagnosis of Ectopic Schistosomiasis Haematobium Infection in a Traveler Returning from the Republic of the Congo.
Loridant S; Mouahid G; Cornu M; Allienne JF; Leroy J; Maurage CA; Fréalle E; Assaker R; Zairi F; Dutoit E; Moné H; Sendid B
Am J Trop Med Hyg; 2018 Jul; 99(1):94-96. PubMed ID: 29714164
[TBL] [Abstract][Full Text] [Related]
39. Effects of miconazole/clotrimazole and praziquantel combinations against the liver fluke Opisthorchis felineus in vivo and in vitro.
Pakharukova MY; Pakharukov YV; Mordvinov VA
Parasitol Res; 2018 Jul; 117(7):2327-2331. PubMed ID: 29721656
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of praziquantel and Ro 15-5458, a 9-acridanone-hydrazone derivative, against Schistosoma haematobium.
Guirguis FR
Arzneimittelforschung; 2003; 53(1):57-61. PubMed ID: 12608016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
